FIELD: medicine.
SUBSTANCE: invention relates to compounds characterized by high antibacterial activity of general formula (I), where R1-R2 have values given in description. Invention also relates to pharmaceutical compositions containing said compounds, and to use of said compounds for treating and/or preventing infectious diseases, including those caused by antibiotic-resistant pathogens (including multiresistant strains), in particular, staphylococcal aetiology, e.g. infectious diseases of skin and/or soft tissues, pneumonia, endocarditis or osteomyelitis.
EFFECT: proposed is use of 6-fluoro-3-triazenone indoles for therapy of MRSA-induced infections.
14 cl, 1 dwg, 5 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
THIAZOLINO-2-PYRIDONES WITH CONDENSED RINGS IN COMBINATION WITH A DRUG AGAINST TUBERCULOSIS | 2018 |
|
RU2791467C2 |
SUBSTITUTED 4-{[4-(3,3-DIOXIDO-1,3-BENZOXATHIOL-6-YL)ARYLOXY]METHYL}PIPERIDINES AS GPR119 RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR PRODUCING AND USING THEM | 2014 |
|
RU2576037C1 |
NOVEL PEPTIDE DERIVATIVES AND USE THEREOF | 2015 |
|
RU2699572C2 |
PEPTIDE MACROCYCLES AGAINST ACINETOBACTER BAUMANNII | 2016 |
|
RU2729609C2 |
PIPERAZINO[1,2-A]INDOLE-1-ONES AND [1,4] DIAZEPTINO[1,2-A]INDOLE-1-ONE | 2014 |
|
RU2628126C2 |
NEW ANTIMICROBIAL AGENTS | 2009 |
|
RU2522582C2 |
SUBSTITUTED 2-THIOXO-IMIDAZOLIDIN-4-ONE, AND SPIROANALOGUES THEREOF, ANTICANCER ACTIVE INGREDIENT, PHARMACEUTICAL COMPOSITION, MEDICINAL PRODUCT, METHOD OF TREATING PROSTATE CANCER | 2014 |
|
RU2557235C1 |
NEW DISPIRO-INDOLINONES, MDM2/p53 INTERACTION INHIBITORS, METHOD FOR PRODUCTION AND APPLICATION | 2015 |
|
RU2629750C2 |
DERIVATIVES OF 1-(3-AMINOPHENYL)-6,8-DIMETHYL-5-(4-IODO-2-FLUORO-PHENYLAMINO)-3-CYCLOPROPYL-1H,6H-PYRIDO[4,3-d]PYRIMIDINE-2,4,7-TRIONE AS MEK1/2 INHIBITORS | 2015 |
|
RU2605400C1 |
5-5 CONDENSED RINGS AS C5a INHIBITORS | 2018 |
|
RU2780322C2 |
Authors
Dates
2020-01-28—Published
2019-02-22—Filed